Canopy Growth (CGC) Notes Payables (2024 - 2026)
Canopy Growth (CGC) posted Notes Payables of $20.1 million for Q1 2026, up 233.03% sequentially from $6.0 million in Q1 2025, and up 233.03% YoY from $6.0 million in Q1 2025.
Canopy Growth (CGC) Notes Payables (2024 - 2026) Analysis & Trends
Canopy Growth has reported Notes Payables for 3 years, with the latest figure at $20.1 million in Q1 2026.
- Quarterly Notes Payables rose 233.03% year-over-year to $20.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.1 million (up 233.03% YoY) and the FY2026 annual result came in at $20.1 million, up 233.03% from the prior year.
- Notes Payables climbed to $20.1 million in Q1 2026 per CGC's latest filing, from $6.0 million in the prior quarter.
- Over five years, Notes Payables peaked at $74.2 million in Q1 2024 and troughed at $6.0 million in Q1 2025.
- A 3-year average of $33.4 million and a median of $20.1 million in 2026 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2025 and 2026: Notes Payables tumbled 91.87% in 2025, then soared 233.03% in 2026.
- Over 3 years, Notes Payables stood at $74.2 million in 2024, then sank by 91.87% to $6.0 million in 2025, then jumped by 233.03% to $20.1 million in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $20.1 million, $6.0 million, and $74.2 million for Q1 2026, Q1 2025, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Canopy Growth | 435.44 Mn | 188.43 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.42 Mn |
| Mar 31, 2026 | 20.07 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Mar 31, 2024 | 74.17 Mn |